Document Detail


FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
MedLine Citation:
PMID:  17537758     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We aimed to compare the value of combined positron emission tomography (PET)/CT, PET+CT (viewed side by side), CT alone and PET alone concerning the rTNM stage and influence on therapy in patients with recurrent breast cancer. 44 patients with suspicion of recurrent breast cancer underwent whole-body [18F]-2-fluoro-2-deoxy-d-glucose (FDG)-PET/CT. Images of combined PET/CT, PET+CT, PET alone and CT alone were evaluated by four blinded reader teams. Diagnostic accuracies and influence on therapy were compared. Histology and a mean clinical follow up of 456 days served as the standard of reference. Differences between the staging procedures were tested for statistical significance by McNemar's test. Overall TNM tumour stage was correctly determined in 40/44 patients with PET/CT, in 38/44 with PET+CT, in 36/44 with PET alone and in 36/44 patients with CT alone. No statistically significant difference was detected between all tested imaging modalities. PET/CT changed the therapy in two patients compared with PET+CT, in four patients compared with PET alone and in five patients compared with CT alone. Combined PET/CT appeared to be more accurate in assessing the rTNM and showed a moderate impact on therapy over PET and CT. Minor improvements were noted when compared with PET+CT. Experienced readers might therefore be able to provide accurate staging results for further therapy from separately acquired studies.
Authors:
P Veit-Haibach; G Antoch; T Beyer; H Stergar; R Schleucher; E A M Hauth; A Bockisch
Related Documents :
20213798 - Positron emission tomography-computed tomography adds to the management of salivary gla...
18377828 - The role of pet-ct in the management of patients with advanced cancer of the head and n...
19590618 - The current role of pet-ct in the characterization of hepatobiliary malignancies.
12883728 - Fdg pet in suspected recurrent and metastatic prostate cancer.
20583948 - Preliminary assessment of dynamic contrast-enhanced ct implementation in pretreatment f...
11110958 - Combined perfusion- and diffusion-weighted mr imaging in acute ischemic stroke during t...
Publication Detail:
Type:  Evaluation Studies; Journal Article     Date:  2007-05-30
Journal Detail:
Title:  The British journal of radiology     Volume:  80     ISSN:  1748-880X     ISO Abbreviation:  Br J Radiol     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-08-20     Completed Date:  2007-09-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0373125     Medline TA:  Br J Radiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  508-15     Citation Subset:  AIM; IM    
Affiliation:
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany. patrick.veit@uni-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Breast Neoplasms / pathology*,  radiography,  radionuclide imaging
Colorectal Neoplasms / radiography,  radionuclide imaging,  secondary
Female
Fluorodeoxyglucose F18 / diagnostic use
Humans
Middle Aged
Neoplasm Recurrence, Local / pathology,  radiography,  radionuclide imaging
Neoplasm Staging
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use
Sensitivity and Specificity
Stomach Neoplasms / radiography,  radionuclide imaging,  secondary
Tomography, X-Ray Computed / methods*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate ind...
Next Document:  Infant feeding in the second 6 months of life related to iron status: an observational study.